Neratinib As Extended Adjuvant Therapy In Patients With Her2-Positive/Hr-Positive Early Breast Cancer: Hta-Driven Analyses From The Extenet StudyDiana Luftner,Hans Tesch,Marcus Schmidt,Andreas Hartkopf,Sarah Streicher,Anna Resch,Luca Genovese,Christian Rose,Roberta Valenti,Nadia HarbeckCANCER RESEARCH(2021)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要